Listed

Ouster, Inc.: Form 10-Q for the period ended Sep 30, 2022

Filed with the SEC on Nov 8, 2022 and accepted by EDGAR at Nov 8, 2022, 17:11 ET.

Share

Management's discussion and analysis

As filed, 64,226 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion of the results of operations and financial condition of Ouster, Inc. (“we,” “us,” “our,” the “Company,” “Ouster”) should be read in conjunction with the information set forth in our condensed consolidated financial statements and the notes thereto included elsewhere in this Form 10-Q, as well as our audited consolidated financial statements and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Ouster’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on February 28, 2022. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties. Ouster’s actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in the section titled “Risk Factors” in Ouster’s Annual Report on Form 10-K dated and filed with the SEC on February 28, 2022, as may be updated from time to time in the Company’s other filings with the SEC.

On December 21, 2020, Ouster Technologies, Inc. (“OTI”, and prior to the Colonnade Merger defined below, named Ouster, Inc.) entered into an Agreement and Plan of Merger (the “Colonnade Merger Agreement”) with Colonnade Acquisition Corp., a Cayman Islands exempted company (“CLA” with CLA after the transactions pursuant to the Colonnade Merger Agreement being referred to as the “Company”), and Beam Merger Sub, Inc. (“Beam Merger Sub”), a Delaware corporation and subsidiary of CLA. OTI’s and CLA’s board of directors unanimously approved OTI’s entry into the Colonnade Merger Agreement, and on March 11, 2021, the transactions contemplated by the Colonnade Merger Agreement were consummated (all such transactions, the “Colonnade Merger”), as further described below.

Unless the context otherwise requires, references in this subsection to “we”, “our” and “the Company” refer to the business and operations of OTI (formerly known as Ouster, Inc.) and its consolidated subsidiaries prior to the Colonnade Merger and to Ouster, Inc. (formerly known as Colonnade Acquisition Corp.) and its consolidated subsidiaries following the consummation of the Colonnade Merger.

Overview

We are a leading provider of high-resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets, allowing each to understand and visualize the surrounding world and ultimately enabling safe operation and autonomy. We design and manufacture digital lidar sensors that we believe are the highest-performing, lowest-cost lidar solutions available today across each of our four target markets: industrial automation; smart infrastructure; robotics; and automotive. We shipped sensors to approximately 680 customers in the twelve months ended September 30, 2022.

Our digital lidar sensors leverage a simplified architecture based on two semiconductor chips and are backed by a suite of patent-protected technology. We have heavily invested in patents since our inception, pursuing comprehensive coverage of invention families and use cases, with broad international coverage. We believe that our extensive patent coverage creates material barriers to entry for anyone aiming to compete in the digital lidar space.

Our product offering today includes our OS scanning product line and our DF solid-state product line. With our unique digital lidar technology, we offer numerous customization options across our products, all enabled by flexible technology and embedded software. Today, we offer short, medium, and long-range lidar products at varying price points and with tailored capabilities to meet the different needs of our diverse customer base.

We believe the simplicity of our digital lidar design gives us a meaningful advantage in costs related to manufacturing, supply chain and production yields. The same digital lidar components underpin our entire product portfolio, which we believe drives economies of scale in our supply chains. With virtually unlimited software-defined products driving low-cost customization, we are able to increase stock keeping units (“SKUs”) for industry-specific applications, expanding our product offering with minimal manufacturing or inventory changes. We currently offer many different software-defined product SKUs, all based on this common architecture and shared core componentry. Additionally, by outsourcing to our manufacturing partner, Benchmark Electronics, Inc. (“Benchmark”), we are able to successfully expand our manufacturing capacity. Benchmark manufactures our products at its facility in Thailand, which we expect will reduce our product costs and allow us to rapidly scale production to meet our anticipated product demand. Based on cost quotes for our products in mass production, we believe our manufacturing costs to be lower than certain of our competitors, and we expect our manufacturing costs per unit to decrease further with higher volumes.

We have won and are actively negotiating several multi-year sales contracts, including certain Strategic Customer Agreements (“SCAs”), which establish a multi-year purchase and supply framework for Ouster and the customer, and include details about customer programs and applications where the customer intends to use Ouster products. SCAs also include multi-year non-binding customer forecasts (typically of three to five years in length) giving Ouster visibility to the customer's long- term purchasing requirements, mutually agreed upon pricing over the duration of the agreement, and, in certain cases, include multi-year binding purchase commitments.

We founded Ouster in 2015 with the invention of our high-performance digital lidar. Since then, we have grown to approximately 290 employees serving approximately 680 customers globally in the twelve months ended September 30, 2022. To continue to grow our business in the coming years, we have expanded and plan to continue to expand our sales and marketing efforts and our software development capabilities, and to accelerate sensor development efforts. We are headquartered in San Francisco, CA.

Merger with Velodyne Lidar, Inc.

On November 4, 2022, we, Velodyne Lidar, Inc. (“Velodyne”), Oban Merger Sub, Inc., and Oban Merger Sub II LLC entered into an Agreement and Plan of Merger (the “Velodyne Merger Agreement”). Pursuant to the Velodyne Merger Agreement, and subject to the satisfaction or waiver of the conditions specified therein, the parties have agreed that we will merge with Velodyne in an all-stock transaction (the “Velodyne Merger”). Under the terms of the agreement, each Velodyne share of common stock will be exchanged for 0.8204 shares of Ouster common stock at closing. The transaction will result in existing Velodyne and Ouster stockholders each owning approximately 50% of the combined company.

Simultaneously with the execution of the Velodyne Merger Agreement, Velodyne entered into a Voting and Support Agreement (the “Velodyne Voting and Support Agreement”) with its directors and officers, and we entered into a voting and support agreement with Banyan Venture Holdings and our directors and officers (the “Ouster Voting and Support Agreement”).

Pursuant to the Ouster Voting and Support Agreement, Banyan Venture Holdings and our directors and officers have agreed, among other things, to vote their respective shares in favor of the adoption of the Velodyne Merger Agreement. Pursuant to the Velodyne Voting and Support Agreement, Velodyne’s directors and officers have agreed, among other things, to vote their respective shares in favor of the adoption of the Velodyne Merger Agreement.

The Velodyne Merger is subject to customary closing conditions including stockholder approval by both companies. Both companies will continue to operate their businesses independently until the close of the Velodyne Merger. The Velodyne Merger is expected to be completed in the first half of 2023.

For additional information regarding the terms of the Velodyne Merger, see Note 14, Subsequent Events to our unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.

REV7 Product Launch

On October 19, 2022, we announced the launch of our newest OS series scanning sensors, REV7, powered by our next-generation L3 chip. REV7 features the all-new OSDome sensor, as well as upgraded OS0, OS1, and OS2 sensors that deliver double the range, enhanced object detection, increased precision and accuracy, and greater reliability. The new REV7 sensors offer performance upgrades that we believe will enhance Ouster’s market opportunity, driven by new opportunities for longer-range and mapping applications.

Merger Agreement with Colonnade Acquisition Corp. and Beam Merger Sub, Inc.

On December 21, 2020, OTI entered into the Colonnade Merger Agreement with CLA, and Beam Merger Sub, a subsidiary of CLA. OTI’s and CLA’s board of directors unanimously approved OTI’s entry into the Colonnade Merger Agreement, and on March 11, 2021, the transactions contemplated by the Colonnade Merger Agreement were consummated. Pursuant to the terms of the Colonnade Merger Agreement, (i) CLA domesticated as a corporation incorporated under the laws of the State of Delaware (the “Domestication”) and changed its name to “Ouster, Inc.” (with CLA after such domestication and the other transactions pursuant to the Colonnade Merger Agreement being referred to as the “Company”) and (ii) Beam Merger Sub merged with and into OTI (the “Colonnade Merger”), with OTI surviving the Colonnade Merger.

As a result of and upon the effective time of the Domestication, among other things, (1) each of the then issued and outstanding 5,000,000 CLA Class B ordinary shares, par value $0.0001 per share, of CLA (the “CLA Class B ordinary shares”) converted automatically, on a one-for-one basis, into a CLA Class A ordinary share (as defined below), (2) immediately following the conversion described in clause (1), each of the then issued and outstanding 25,000,000 Class A ordinary shares, par value $0.0001 per share, of CLA (the “CLA Class A ordinary shares”), converted automatically, on a one-for-one basis, into a share of common stock, par value $0.0001 per share, of Ouster (the “Ouster common stock”), (3) each of the then issued and outstanding 10,000,000 redeemable warrants of CLA (the “CLA warrants”) converted automatically into a redeemable warrant to purchase one share of Ouster common stock (the “Public warrants”) pursuant to the Warrant Agreement, dated August 20, 2020 (the “Warrant Agreement”), between CLA and Continental Stock Transfer & Trust Company (“Continental”), as warrant agent, and (4) each of the then issued and outstanding units of CLA that had not been previously separated into the underlying CLA Class A ordinary shares and underlying CLA warrants upon the request of the holder thereof (the “CLA units”), were cancelled and entitled the holder thereof to one share of Ouster common stock and one-half of one Public warrant, and (5) each of the then issued and outstanding 6,000,000 private placement warrants of CLA (the “Private Placement warrants”) converted automatically into a Public warrant pursuant to the Warrant Agreement. No fractional Public warrants were issued upon separation of the CLA units.

Immediately prior to the effective time of the Colonnade Merger, (1) each share of OTI’s Series B Preferred Stock, par value $0.00001 per share (the “OTI Preferred Stock”), converted into one share of common stock, par value $0.00001 per share, of OTI (the “OTI common stock” and, together with OTI Preferred Stock, the “OTI Capital Stock”) (such conversion, the “OTI Preferred Conversion”) and (2) all of the outstanding warrants to purchase shares of OTI Capital Stock were exercised in full or terminated in accordance with their respective terms (the “OTI Warrant Settlement”).

As a result of and upon the closing of the Colonnade Merger, among other things, all shares of OTI Capital Stock (after giving effect to the OTI Warrant Settlement) outstanding immediately prior to the closing of the Colonnade Merger together with shares of OTI common stock reserved in respect of options to purchase shares of OTI common stock and restricted shares of OTI common stock (together, the “OTI Awards”) outstanding immediately prior to the closing of the Colonnade Merger that were converted into awards based on Ouster common stock, were cancelled in exchange for the right to receive, or the reservation of, an aggregate of $1.5 billion of shares of Ouster common stock (at a deemed value of $10.00 per share), which, in the case of OTI Awards, were shares underlying awards based on Ouster common stock, representing a fully-diluted pre-transaction shares. Upon the closing of the Colonnade Merger, the Company received gross proceeds of $299.9 million from the Colonnade Merger and private offering, offset by $8.5 million of pre-merger costs relating to CLA and transaction costs of $26.6 million.

Sense Acquisition

On October 22, 2021, we completed the acquisition of Sense Photonics, Inc. (“Sense”). Under the terms of the merger agreement, we acquired 100% of Sense and all of its property for approximately 10 million shares of Ouster common stock or approximately $63.0 million in equity value based on the closing price of $6.55 per share as of the day the transaction closed on October 22, 2021, inclusive of 0.8 million shares underlying assumed options, after closing adjustments. This acquisition is expected to help Ouster expand its presence in the automotive vertical by executing on our hiring goals and product roadmap on a faster timeline.

COVID-19 Impact

Our suppliers who are located worldwide, including some of our key suppliers, have been affected by the novel coronavirus (“COVID-19”) pandemic, resulting in persistent supply chain disruptions. We have been experiencing unfavorable purchase price variance and situational expedite fees in order to meet production and delivery timelines. While we may experience additional and new pressures on our supply chain that may or may not be related to the pandemic, we have been actively taking steps to mitigate the impact of the materials shortages on our business.

Some customers have delayed their orders and production schedules. In spite of what appears to be a “return-to-normal” in several regions, the pandemic continues to evolve, and the full extent to which it will directly or indirectly impact our business, results of operations and financial condition, including sales, expenses, reserves and allowances, manufacturing, research and development costs and personnel-related costs, will depend on future developments that are uncertain, including new information that may emerge concerning COVID-19, the impact of new variants and sub-variants and the actions taken to contain, prevent or treat COVID-19, rate and success of vaccination efforts, vaccination reticence, resurgence of the pandemic in areas where we, Benchmark or our suppliers operate, and the economic impact on local, regional, national and international customers and markets.

Because the situation remains uncertain and hard to predict, the COVID-19 pandemic may have a material negative impact on our future results.

Factors Affecting Our Performance

Supply Chain Continuity. Beginning in 2021, a surge in demand for electronics containing semiconductor chips and stockpiling of chips by certain companies created disruptions in the supply chain, which continue to persist and have resulted in a global chip shortage impacting our industry. Some chip manufacturers continue to estimate that this supply shortage may continue through the end of 2023. These chip manufacturers are working to increase capacity in the future, and we are managing our inventory and working closely with our regular suppliers and customers to minimize the potential impacts of any supply shortages including by securing additional inventory. While we do not expect the shortage to have a material near-term impact on our ability to meet existing demand for our current products, the shortage adversely impacted our gross margins for the year ended December 31, 2021 and the nine months ended September 30, 2022 and may continue to do so. We anticipate fluctuation in our cost of goods sold over the next 12-15 months as a result of ongoing supply chain constraints. These constraints have caused and may in the future cause us to implement certain temporary price surcharges. Over time, we expect our overall average selling prices to decline as our volume increases. If our mitigating efforts are not successful or the shortage continues or worsens in ways we did not anticipate, our ability to supply or improve our current products as well as our development and rollout of future products could also be adversely affected.

Commercialization of Lidar Applications. We believe that lidar is approaching its inflection point of adoption across our target end market applications, and that we are well-positioned to capitalize on this market adoption. However, as our customers continue research and development projects to commercialize semi-autonomous solutions that rely on lidar technology, it is difficult to estimate the timing of ultimate end market and customer adoption. As a result, we expect that our results of operations, including revenue and gross margins, will continue to fluctuate on a quarterly and annual basis for the foreseeable future. As the market for lidar solutions matures and more customers reach a commercialization phase with solutions that rely on our technology, the fluctuations in our operating results may become less pronounced. Nonetheless, our revenue may not grow as we expect unless and until more customers commercialize their products and lidar technology becomes more prevalent across our target end markets.

Number of Customers in Production. For certain strategic customers and markets, our products must be integrated into a broader platform, which then must be tested, validated, and achieve system-level performance and reliability thresholds that enable commercial production and sales. The time necessary to reach commercial production varies from six months to seven years, based on the market and application. For example, the production cycle in the automotive market tends to be substantially longer than in our other target markets, including industrial automation, smart infrastructure and robotics. It is critical to our future success in each of our target end markets that our customers reach commercial production and sales and that they select our products in their commercial production applications. Because the timelines to reach production vary significantly and the revenue generated by each customer in connection with commercial production and sales is unpredictable, it is difficult for us to reliably predict our financial performance.

Customers’ Sales Volumes. Our customer base is diversified and we intend to penetrate into diverse end markets to increase our sales volumes. Ultimately widespread adoption of our customers’ products that incorporate our lidar solutions will depend on many factors, including the size of our customers’ end markets, end market penetration of our customer’s products that incorporate our digital lidar solutions, our end customers’ ability to sell their products, and the financial stability and reputation of the customers. We believe our sales volume by customer depends on the end market demand for our customers’ products that incorporate our digital lidar solutions as well as our ability to grow our sales force.

Average Selling Prices (“ASPs”), Product Costs and Margins. Our product costs and gross margins depend largely on the volumes of sensors sold and the number and variety of solutions we provide to our customers. We expect that our selling prices will vary by target end market and application due to market-specific supply and demand dynamics. We expect to continue to experience some downward pressure on margins from signing anticipated large multi-year agreements (including our SCAs) in the near term with multi-year negotiated pricing, as well as the supply chain constraints discussed above. We expect that these customer-specific selling price fluctuations combined with our volume-driven product costs may drive fluctuations in revenue and gross margins on a quarterly basis. However, notwithstanding any short-term price surcharges on our products, we expect that over time our volume-driven product costs will lead to gross margin improvement as our sales volume increases.

Competition. Lidar is an emerging market, and there are competitors for the growing market. Competitors may offer lidar products at lower prices than ours, including pricing that may be below their cost, or may offer superior performing lidar products. These companies also compete with us indirectly by attempting to solve some of the same challenges with different technology. Established competitors in the market for lidar sensors have significantly greater resources and more experience than we do. These competitors have commercialized lidar technology that has achieved market adoption, strong brand recognition and may continue to improve in both anticipated and unanticipated ways. They may also enter, and have entered, into commercial relationships with key customers and potential customers and have built relationships and dependencies between themselves and those key customers and potential customers. This has created downward pressure on our ASPs, particularly in the Asia and Pacific region. We expect this pressure to continue to push our ASPs lower in the coming years. However, we believe that because of our complementary metal-oxide-semiconductor (“CMOS”), digital lidar technology, we are in the position to scale more rapidly than our analog competitors and leverage our scale to deliver positive gross margins.

Continued Investment and Innovation. We believe that we are a leading digital lidar provider. Our financial performance is significantly dependent on our ability to maintain this leading position which is further dependent on the investments we make in research and development. We believe it is essential that we continue to identify and respond to rapidly evolving customer requirements, including successfully realizing our product roadmap. If we fail to continue our innovation, our market position and revenue may be adversely affected, and our investments in that area will not be recovered.

Market Trends and Uncertainties. We anticipate robust demand for our digital lidar solution. We estimate a multibillion-dollar total addressable market (“TAM”) for our solutions in the near future. We define our TAM as automation applications in the industrial, smart infrastructure, robotics and automotive end markets where we actively engage and maintain customer relationships. Each of our target markets is potentially a significant global opportunity, and these markets have historically been underserved by limited or inferior technology or not served at all. We believe we are well positioned in our market as a leading provider of high-resolution digital lidar sensors.

Although increasing adoption of semi-autonomous solutions that rely on lidar technology may generate higher demand, we may not be able to take advantage of demand if we are unable to anticipate regulatory changes and adapt quickly enough to meet such new regulatory standards or requirements applicable to us or to our customers’ products in which our digital lidar sensors are used. Market acceptance of semi-autonomous solutions and active safety technology depend upon many factors, including cost, performance, safety, regulatory requirements and international taxes or tariffs related to such technologies. These factors may impact the ultimate market acceptance of our lidar technology.

International Expansion. We view international expansion as an important element of our strategy to increase revenue and achieve profitability. We continue to position ourselves in geographic markets that we expect to serve as important sources of future growth. We have an existing presence in three regions: North and South America; Asia and Pacific; and Europe, Middle East and Africa. We intend to expand our presence in these regions over time including through distribution partnerships. Expanded global reach will require continued investment and may expose us to additional foreign currency risk, international taxes and tariffs, legal obligations and additional operational costs, risks and challenges that may impact our ability to meet our projected sales volumes, revenue and gross margins.

Components of Results of Operations

Revenue

The majority of our revenue comes from the sale of our digital lidar sensors and accessories both directly to end users and through distributors domestically and internationally. We recognize revenue from product sales when the performance obligation of transferring control of the product to the customer has been met, which is generally when the product is shipped. We also recognize revenue by performing services related to product development and validation, and shipping; however, we do not expect product development and validation and license and services to be material components of revenue, cost of revenue or gross margin in the foreseeable future. Performance obligations related to services are generally recognized over time, based on cost-to-cost input basis or straight-line over time. Amounts billed to customers related to shipping and handling are classified as product revenue, and we have elected to recognize the cost of shipping activities that occur after control has transferred to the customer as a fulfillment cost rather than a separate performance obligation. All related costs are accrued and recognized within cost of revenue when the related revenue is recognized.

Most of our customers are currently in the evaluation or early research and development (“R&D”) stage with our products. Currently, our product revenue consists of both customers ordering small volumes of our products that are in an evaluation phase and customers that order larger volumes of our products and have more predictable long-term production schedules. However, we are still at the very beginning of the lidar adoption curve, and some customers are still learning their ramp rates which can impact the timing of purchase orders quarter to quarter. As we grow our business, we expect to improve predictability into our customers’ needs and timelines, and expect the timing of orders will have a less notable impact on our quarterly results. Over the coming years, as more of our customers move into their respective production phases, we expect the majority of our product revenue to shift to larger volume orders based on predictable production schedules.

Cost of Revenue

Cost of revenue consists of the manufacturing cost of our digital lidar sensors, which primarily consists of sensor components, personnel-related costs directly associated with our manufacturing organization, and amounts paid to our third-party contract manufacturer and vendors. Our cost of revenue also includes depreciation of manufacturing equipment, an allocated portion of overhead, facility and IT costs, stock-based compensation for manufacturing personnel, reserves for estimated warranty expenses, excess and obsolete inventory and shipping costs.

Gross Profit and Gross Margin

Our gross profit equals total revenues less our total cost of revenues, and our gross margin is our gross profit expressed as a percentage of total revenue. Subject to quarterly fluctuations and volatility, we expect unit costs to improve as we manufacture higher unit volumes of sensors and a greater portion of our sensors are produced by our contract manufacturer in Thailand.

Operating Expenses

Research and Development Expenses

R&D activities are primarily conducted at our San Francisco based headquarters and our additional R&D facility in Edinburgh, Scotland and consist of the following activities:

  • Design, prototyping, and testing of proprietary electrical, optical, and mechanical subsystems for our digital lidar products;
  • Robust testing for industrial and autonomous vehicle safety certifications;
  • Development of new products and enhancements to existing products in response to customer requirements including firmware development and software development of lidar integration products;
  • Custom system-on-a-chip (“SoC”) design for Ouster’s digital lidar products; and
  • Development of custom manufacturing equipment.

R&D expenses consist of personnel-related expenses, including salaries, benefits, and stock-based compensation, for all personnel directly involved in R&D activities, third-party engineering and contractor costs, and prototype expenses.

R&D costs are expensed as they are incurred. We expect our investment in R&D will continue to grow as we invest in new lidar technology and related software; however, we expect R&D as a percentage of revenue to decrease annually as our business grows.

Sales and Marketing Expenses

Our business development, customer support and marketing teams are located in offices worldwide. Selling and marketing expenses consist of personnel-related expenses, including salaries, benefits, and stock-based compensation, for all personnel directly involved in business development, customer support, and marketing activities, and marketing expenses including trade shows, advertising, and demonstration equipment. We expect that our investment in sales and marketing will continue to grow as we continue to expand our sales team globally, and our absolute amount of sales and marketing expenses will grow over time. We expect sales and marketing spend as a percentage of revenue to decrease over time as our business grows.

General and Administrative Expenses

General and administrative expenses consist of personnel-related expenses, including salaries, benefits, and stock-based compensation, of our executives and members of the board of directors, finance, human resource, IT, and legal departments as well as fees related to legal fees, patent prosecution, accounting, finance and professional services, insurance, and bank fees. We expect our absolute amount of general and administrative expense will grow over time; however, we expect the general and administrative spend as a percentage of revenue to decrease annually as our business grows. Near term increases in general and administrative expenses are expected to be related to hiring more personnel and consultants to support our growing international expansion and compliance with the applicable provisions of U.S. generally accepted accounting principles and other SEC rules and regulations.

Stock-Based Compensation

We measure stock options granted based on the fair value on the date of the grant and recognize compensation expense of those awards, over the requisite service period, which is the vesting period of the respective award. Forfeitures are accounted for as they occur. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option pricing model. The grant date fair value of restricted stock unit awards is based on the grant date share price.

Interest Income, Interest Expense, and Other Income (Expense), Net

Interest income consists primarily of income earned on our cash and cash equivalents. These amounts will vary based on our cash and cash equivalents balances and market rates. Interest expense consists primarily of interest on our debt and convertible notes and amortization of debt issuance costs and discount. Other income (expense), net consists primarily of realized and unrealized gains and losses on foreign currency transactions and balances, the change in fair value of financial instruments, including warrants issued in connection with a debt agreement, and private placement warrants acquired as part of the Colonnade Merger.

Income Taxes

Our income tax provision consists of federal, state and foreign current and deferred income taxes. Our income tax provision for interim periods is determined using an estimate of our annual effective tax rate, adjusted for discrete items arising in the quarter. Our effective tax rate differs from the U.S. statutory tax rate primarily due to valuation allowances on its deferred tax assets as it is more likely than not that some, or all, of our deferred tax assets will not be realized. We continue to maintain a full valuation allowance against its net deferred tax assets. Income tax provision for the three and nine months ended September 30, 2022 and 2021, respectively, was not material to the Company’s condensed consolidated financial statements.

Results of Operations:

The following table sets forth our condensed consolidated results of operations data for the periods presented:

(dollars in thousands)

(dollars in thousands)

Three Months Ended September 30, 2022 2021 Nine Months Ended September 30, 2022 2021
Product revenue $11,204 $7,755 $30,091 $21,726
Cost of product revenue(1) 7,488 5,879 21,002 16,212
Gross profit 3,716 1,876 9,089 5,514
Operating expenses(1):
Research and development 17,212 8,390 49,011 19,576
Sales and marketing 8,541 6,737 23,194 14,777
General and administrative 14,008 14,073 40,306 36,177
Total operating expenses 39,761 29,200 112,511 70,530
Loss from operations (36,045) (27,324) (103,422) (65,016)
Other (expense) income:
Interest income 733 165 1,231 305
Interest expense (699) — (1,143) (504)
Other income (expense), net 61 14,490 7,071 (422)
Total other expense, net 95 14,655 7,159 (621)
Loss before income taxes (35,950) (12,669) (96,263) (65,637)
Provision for income tax expense 37 — 121 —
Net loss $(35,987) $(12,669) $(96,384) $(65,637)

36

The following table sets forth the components of our condensed consolidated statements of operations and comprehensive loss data as a percentage of revenue for the periods presented:

Three Months Ended September 30, 2022 (% of total revenue) 2021 Nine Months Ended September 30, 2022 (% of total revenue) 2021
Product revenue 100% 100% 100% 100%
Cost of product revenue(1) 67 76 70 75
Gross profit 33 24 30 25
Operating expenses (1):
Research and development 154 108 163 90
Sales and marketing 76 87 77 68
General and administrative 125 181 134 167
Total operating expenses 355 377 374 325
Loss from operations (322) (352) (344) (299)
Other (expense) income:
Interest income 7 2 4 1
Interest expense (6) 0 (4) (2)
Other income (expense), net 1 187 23 (2)
Total other expense, net 1 189 24 (3)
Loss before income taxes (321) (163) (320) (302)
Provision for income tax expense — — — —
Net loss (321)% (163)% (320)% (302)%

(1) Includes stock-based compensation expense as follows:

(dollars in thousands)

(dollars in thousands)

Three Months Ended September 30, 2022 2021 Nine Months Ended September 30, 2022 2021
Cost of product revenue $207 $206 $570 $457
Research and development 3,681 2,063 11,248 4,305
Sales and marketing 1,913 1,717 5,276 2,702
General and administrative 2,654 3,161 8,230 11,093
Total stock-based compensation $8,455 $7,147 $25,324 $18,557

37

Comparison of the three months ended September 30, 2022 and 2021

Revenue

(dollars in thousands)

Three Months Ended September 30, 2022 2021 Change $% Change
Product revenue $11,204 $7,755 $3,449 44%
Revenue by geographic location:
United States $4,010 $4,037 $(27) (1)%
North and South America, excluding United States 172 147 25 17
Asia and Pacific 2,072 1,957 115 6
Europe, Middle East and Africa 4,950 1,614 3,336 207
Total $11,204 $7,755 $3,449 44%

Product Revenue

Product revenue increased by $3.4 million, or 44%, to $11.2 million for the three months ended September 30, 2022 from $7.8 million for the comparable period in the prior year. The increase in product revenue was driven by a 31% increase in volume which we attribute primarily to the global expansion of our sales team and the increase of high volume, long-term agreements as some of our customers begin to move into a production stage with their autonomous products. Our average selling price increased by 11% when compared to the comparable period in the prior year.

Geographic Locations

Revenue increased across the geographic regions of North and South America, excluding the United States; Asia and Pacific; and Europe, Middle East and Africa as compared to the comparable period in the prior year. The revenue increases in those geographic regions was primarily attributable to our continued focus and investment in our global sales team and an expansion in the demand of our existing customers as 13% of our revenue was from new customers during the three months ended September 30, 2022. We specifically saw large growth in the Europe, Middle East and Africa as several of our customers with whom we have strategic customer agreements (SCAs) made production buys in the three months ended September 30, 2022. The United States product revenue remained relatively flat period-over-period.

Cost of Product Revenue and Gross Margin

(dollars in thousands)

Three Months Ended September 30, 2022 2021 Change $% Change
Cost of product revenue $7,488 $5,879 $1,609 27%

Cost of product revenue increased by $1.6 million, or 27%, to $7.5 million for the three months ended September 30, 2022 from $5.9 million for the comparable period in the prior year. The increase in cost of product revenue was primarily attributable to increases related to volume of $1.1 million in material, manufacturing, and freight costs, $1.7 million general increases per unit in material, manufacturing, and freight costs associated with rising prices from inflation and the ongoing global supply chain shortages. The increases were partially offset by a decrease of $1.2 million in purchase price variance as we invested in securing material in response to the global supply chain shortages in the previous periods.

Product gross margin increased from 24% for the three months ended September 30, 2021 to 33% for the three months ended September 30, 2022. The increase in product gross margin was due to the 11% increase in average selling price and 3% favorable decrease in cost of product revenue per unit.

Operating Expenses

(dollars in thousands)

Operating expenses: Three Months Ended September 30, 2022 2021 Change $% Change
Research and development $17,212 $8,390 $8,822 105%
Sales and marketing 8,541 6,737 1,804 27
General and administrative 14,008 14,073 (65) —
Total operating expenses: $39,761 $29,200 $10,561 36%

Research and Development

Research and development expenses increased by $8.8 million, or 105%, to $17.2 million for the three months ended September 30, 2022 from $8.4 million for the comparable period in the prior year. The increase was primarily attributable to an increase of $1.4 million in stock-based compensation expense, $3.4 million in payroll-related expenses, $0.6 million in depreciation and amortization expense, $2.7 million increase in contractor, prototype, and equipment costs related to product development, and $0.7 million in other materials and supplies, facilities, professional fees and other miscellaneous costs attributable to research and development functions. The increase in employee-related costs was mainly due to the higher headcount associated with the Sense Photonics, Inc. acquisition.

Sales and Marketing

Sales and marketing expenses increased by $1.8 million, or 27%, to $8.5 million for the three months ended September 30, 2022 from $6.7 million for the comparable period in the prior year. The increase was primarily attributable to an increase of $1.1 million in payroll and personnel-related costs, $0.2 million in stock-based compensation expense driven by the addition of sales personnel in all our global regions and $0.5 million in professional, travel and other costs related to sales and marketing activities.

General and Administrative

General and administrative expenses decreased by $0.1 million, or 0.5%, to $14.0 million for the three months ended September 30, 2022 from $14.1 million for the comparable period in the prior year. The change was primarily attributable to an increase of $0.5 million in payroll and personnel-related costs, $0.5 million in depreciation expenses and $0.6 million in office, facility and other expenses, $0.6 million in litigation costs, partially offset by a decrease of $0.5 million in stock-based compensation expenses, and $1.8 million in professional services fees.

Interest Income, Interest Expense and Other Income (Expense), Net

(dollars in thousands)

Three Months Ended September 30, 2022 2021 Change $% Change
Interest income $733 $165 $568 344%
Interest expense (699) — (699) *
Other income (expense), net 61 14,490 (14,429) (100)

*Not meaningful

The increase in interest income was primarily attributable to improved cash management activities to earn a higher yield on excess cash and cash equivalent balances.

Interest expense was $0.7 million for the three months ended September 30, 2022 relating to term loan borrowings and amortization of debt issuance costs and discount under our Loan Agreement (as defined below). There was no interest expense in the three months ended September 30, 2021 as we did not have outstanding debt in that period.

Other income (expense), net was $0.1 million for the three months ended September 30, 2022 compared to $14.5 million for the comparable period in the prior year. During the three months ended September 30, 2022, we recorded a gain of $0.2 million for the fair value change of the private placement warrant liability. During the comparable period in the prior year, we recorded a loss of $14.5 million for the fair value change of the private placement warrant liability.

Income Taxes

We were subject to income taxes in the United States, California, and miscellaneous foreign jurisdictions for the three months ended September 30, 2022 and 2021. Our income tax expense for three months ended September 30, 2022 and 2021 was not material to our condensed consolidated financial statements.

Comparison of the Nine Months Ended September 30, 2022 and 2021

Revenue

(dollars in thousands)

Nine Months Ended September 30, 2022 2021 Change $% Change
Product revenue $30,091 $21,726 $8,365 39%
Revenue by geographic location:
United States $9,850 $8,463 $1,387 16%
North and South America, excluding United States 835 675 160 24
Asia and Pacific 7,004 4,904 2,100 43
Europe, Middle East and Africa 12,402 7,684 4,718 61
Total $30,091 $21,726 $8,365 39%

Product Revenue

Product revenue increased by $8.4 million, or 39%, to $30.1 million for the nine months ended September 30, 2022 from $21.7 million for the comparable period in the prior year. The increase in product revenue was driven by an increase in volume of 40%, which we attribute primarily to the global expansion of our sales team and the increase of high volume, long-term deals as some of our customers begin to move into a production stage with their autonomous products. Our average selling price declined by 1% when compared to the comparable period in the prior year.

Geographic Locations

Revenue increased across the geographic regions of the United States; North and South America, excluding the United States; Asia and Pacific; and Europe, Middle East and Africa by $1.4 million, $0.2 million, $2.1 million, and $4.7 million, respectively, as compared to the comparable period in the prior year. The revenue increases in those geographic regions were a result of our continued focus and investment in our global sales team and an expansion in the demand of our existing customers since only 22% of our revenue was from new customers during the nine months ended September 30, 2022.

Cost of Product Revenue and Gross Margin

(dollars in thousands)

Nine Months Ended September 30, 2022 2021 Change $% Change
Cost of product revenue $21,002 $16,212 $4,790 30%

Cost of product revenue increased by $4.8 million, or 30%, to $21.0 million for the nine months ended September 30, 2022 from $16.2 million for the comparable period in the prior year. The increase in cost of product revenue was primarily due to an increase of $0.9 million in purchase price variance due to the supply chain shortage, increases related to volume of $2.4 million in material costs, $0.2 million in freight costs and $1.8 million in manufacturing overhead costs. The increases were partially offset by a decrease of $0.5 million in per unit costs of materials, labor and overhead and other costs related to product revenue.

Product gross margin increased from 25% for the nine months ended September 30, 2021 to 30% for the nine months ended September 30, 2022. The increase in product gross margin was primarily due to the 8% decrease in cost per unit partially offset by the 1% decrease in average selling price.

Operating Expenses

(dollars in thousands)

Operating expenses: Nine Months Ended September 30, 2022 2021 Change $% Change
Research and development $49,011 $19,576 $29,435 150%
Sales and marketing 23,194 14,777 8,417 57
General and administrative 40,306 36,177 4,129 11
Total operating expenses: $112,511 $70,530 $41,981 60%

Research and Development

Research and development expenses increased by $29.4 million, or 150%, to $49.0 million for the nine months ended September 30, 2022 from $19.6 million for the comparable period in the prior year. The increase was primarily attributable to an increase of $12.3 million in payroll and benefits related costs, $6.5 million in stock-based compensation expense, $6.8 million in contractor, prototype, and equipment costs related to product development, $1.9 million in depreciation and amortization expense, and $1.9 million in other materials and supplies, facilities, professional fees and other miscellaneous costs attributable to research and development functions. The increase in employee-related costs was mainly due to the higher headcount associated with the Sense Photonics, Inc. acquisition.

Sales and Marketing

Sales and marketing expenses increased by $8.4 million, or 57%, to $23.2 million for the nine months ended September 30, 2022 from $14.8 million for the comparable period in the prior year. The increase was primarily attributable to an increase of $5.1 million in payroll and personnel-related costs, $2.6 million in stock-based compensation expense driven by the addition of sales personnel in all our global regions, as well as a $0.7 million increase in other expenses associated with our marketing and business development programs.

General and Administrative

General and administrative expenses increased by $4.1 million, or 11%, to $40.3 million for the nine months ended September 30, 2022 from $36.2 million for the comparable period in the prior year. The increase was primarily due to an increase of $3.1 million in payroll and personnel-related costs, $1.2 million in insurance premiums, $1.6 million in depreciation expenses, $1.2 million in litigation costs and $2.2 million in office, facility and other expenses, partially offset by a decrease of $2.9 million in stock-based compensation expenses and $2.3 million in professional services fees.

Interest Income, Interest Expense and Other Income (Expense), Net

(dollars in thousands)

Nine Months Ended September 30, 2022 2021 Change $% Change
Interest income $1,231 $305 $926 304%
Interest expense (1,143) (504) (639) 127
Other income (expense), net 7,071 (422) 7,493 (1,776)

Interest income was $1.2 million for the nine months ended September 30, 2022 compared to $0.3 million for the comparable period in the prior year. The increase in interest income was primarily attributable to improved cash management activities to earn a higher yield on excess cash and cash equivalent balances.

Interest expense was $1.1 million for the nine months ended September 30, 2022 compared to $0.5 million for the comparable period in the prior year. We recorded interest expense on our debt and amortization of debt issuance costs and discount in the nine months ended September 30, 2022 relating to term loan borrowings and amortization of debt issuance costs and discount under our Loan and Security Agreement. Interest expense recorded in the nine months ended September 30, 2021 primarily consisted of interest and amortization of debt issuance cost and discount on the loan and security agreement with Runway Growth Credit and Fund Inc., which was terminated on March 26, 2021.

Other income (expense), net was $7.1 million of income for the nine months ended September 30, 2022 compared to $(0.4) million in expense for the comparable period in the prior year. During the nine months ended September 30, 2022, we recorded a gain of $7.4 million for the fair value change of private placement warrant liability. During the nine months ended September 30, 2021, we recorded a loss of $8.8 million for the fair value change of redeemable convertible preferred stock warrant liability and a gain of $8.4 million for the fair value change of private placement warrant liability.

Income Taxes

We were subject to income taxes in the United States, California, and miscellaneous foreign jurisdictions for the nine months ended September 30, 2022 and 2021. Our income tax expense for nine months ended September 30, 2022 and 2021 was not material to the Company’s condensed consolidated financial statements.

Liquidity and Capital Resources

Our principal sources of liquidity are our cash and cash equivalents, cash generated from product revenues, sales of common stock under our at-the market equity offering program and our Loan Agreement with Hercules Capital, Inc.

Our primary requirements for liquidity and capital are working capital, inventory management, capital expenditures, public company costs and general corporate needs. We expect these needs to continue as we develop and grow our business. Prior to the Colonnade Merger, we primarily funded our operations from the net proceeds from sales of our preferred convertible stock and convertible notes, borrowing under our loan and security agreement with Runway Growth Credit Fund, Inc. and product revenue. Upon closing of the Colonnade Merger, we received gross proceeds of $299.9 million from the Colonnade Merger and private offering, offset by $8.5 million of pre-merger costs relating to CLA and transactions cost of $26.6 million.

On April 29, 2022, we entered into an open market sale agreement with B. Riley Securities, Inc., Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc. (the “ATM Agreement”), pursuant to which we may offer and sell shares of our common stock with an aggregate offering price of up to $150.0 million under an “at the market” offering program. Subject to the terms and conditions of the agreement, we may sell the shares in amounts and at times to be determined by us but we are under no obligation to sell any of the shares. Actual sales, if any, will depend on a variety of factors to be determined by us from time to time, including, among other things, market conditions, the trading price of our common stock, capital needs and determinations by us of the appropriate sources of its funding. During the nine months ended September 30, 2022, we sold 7,833,709 shares of common stock for net proceeds of $15.8 million under the ATM Agreement. We currently intend to use the net proceeds from the sale of shares pursuant to the ATM Agreement for working capital and general corporate purposes.

On April 29, 2022, we entered into a loan and security agreement (the “Loan Agreement”) with Hercules Capital, Inc. (“Hercules”). The Loan Agreement provides us with a term loan of up to $50.0 million, subject to terms and conditions. $20.0 million was drawn under the Loan Agreement on April 29, 2022 and an additional $20.0 million was drawn on October 17, 2022. For additional information, see “Debt Arrangements” below.

As of September 30, 2022, we had an accumulated deficit of $399.7 million and cash and cash equivalents of $133.2 million. We have experienced recurring losses from operations, and negative cash flows from operations, and we expect to continue operating at a loss and to have negative cash flows from operations for the foreseeable future. Because we are in the growth stage of our business and operate in an emerging field of technology, we expect to continue to invest in research and development and expand our sales and marketing teams worldwide. We are likely to require additional capital to respond to technological advancements, competitive dynamics or technologies, customer demands, business opportunities, challenges, acquisitions or unforeseen circumstances and in either the short-term or long-term may determine to engage in equity or debt financings or enter into credit facilities for other reasons. If we are unable to obtain adequate financing or financing on terms satisfactory to us, when we require it, our ability to continue to grow or support our business and to respond to business challenges could be significantly limited. In particular, the widespread COVID-19 pandemic and current macroeconomic conditions, including elevated inflation rates and high interest rates, have resulted in, and may continue to result in, significant disruption of global financial markets, reducing our ability to access capital. If we are unable to raise additional funds when or on the terms desired, our business, financial condition and results of operations could be adversely affected.

Debt Arrangements

As described above, on April 29, 2022, we entered into the Loan Agreement with Hercules, which provides us with a term loan facility of up to $50.0 million, subject to terms and conditions (the “Term Loan Facility”). As of September 30, 2022, $20.0 million has been drawn to date under the Loan Agreement, and can be used for general working capital purposes subject to certain terms and conditions. Subsequent to September 30, 2022 we borrowed an additional $20.0 million. An additional $10.0 million may be drawn on or before June 15, 2023, subject to satisfying certain conditions relating to the achievement of trailing twelve-month revenue and profit milestones.

In contemplation of entry into the Velodyne Merger Agreement, on November 1, 2022, we entered into a Consent and Second Amendment to Loan and Security Agreement (the “Hercules Amendment”), amending the Loan Agreement. Pursuant to the terms of the Hercules Amendment, the financial covenant requiring us to achieve certain trailing twelve month revenue thresholds commencing with the quarter ending June 30, 2023 will be eliminated and replaced, contingent upon and effective as of the closing of the Velodyne Mergers, with a minimum liquidity financial covenant whereby we must maintain at least $60 million of cash in deposit accounts that are subject to an account control agreement in favor of Hercules.

For additional information regarding the terms of the Loan Agreement, see Note 5, Debt and Note 14, Subsequent Events.

Material Cash Requirements

We are a party to many contractual obligations involving commitments to make payments to third parties. These obligations impact our short-term and long-term liquidity and capital resource needs. Certain contractual obligations are reflected on the condensed consolidated balance sheet as of September 30, 2022, while others are considered future commitments. Our contractual obligations primarily consist of non-cancelable purchase commitments with various parties to purchase goods or services, primarily inventory, entered into in the normal course of business, operating leases and obligations related to the Loan Agreement with Hercules. For information regarding our other contractual obligations, refer to Note 7, Commitments and Contingencies and our Annual Report on Form 10-K as filed with the SEC on February 28, 2022. If the Velodyne Merger is consummated, we will assume certain of Velodyne’s contractual obligations.

Cash Flow Summary

(dollars in thousands)

Net cash provided by (used in): Nine months ended September 30, 2022 2021
Operating activities $(83,290) $(45,106)
Investing activities (2,078) (1,774)
Financing activities 35,414 257,826

Operating Activities

During the nine months ended September 30, 2022, operating activities used $83.3 million in cash. The primary factors affecting our operating cash flows during this period were our net loss of $96.4 million, impacted by our non-cash charges of $28.3 million primarily consisting of stock-based compensation of $25.3 million, a $7.4 million change in fair value of warrant liabilities, depreciation and amortization of $7.1 million, change in right-of-use asset of $2.1 million, interest expense and amortization of debt issuance costs and debt discount of $0.4 million. The changes in our operating assets and liabilities of $15.2 million were primarily due to a decrease in operating lease liability of $2.4 million, an increase in accounts payable of $3.2 million, an increase in accounts receivable of $0.1 million and an increase in accrued and other liabilities of $0.2 million.

During the nine months ended September 30, 2021, operating activities used $45.1 million in cash. The primary factors affecting our operating cash flows during this period were our net loss of $65.6 million, impacted by our non-cash charges of $24.8 million primarily consisting of inventory write down of $0.9 million, interest expense and amortization of debt issuance costs and debt discount of $0.3 million, depreciation and amortization of $3.4 million, change in right-of-use asset of $1.3 million, stock-based compensation of $18.6 million. The changes in our operating assets and liabilities of $4.3 million were primarily due to an increase in accounts receivable of $4.4 million, a decrease of accounts payable of $2.7 million, and an increase in accrued and other current liabilities of $7.1 million.

Investing Activities

During the nine months ended September 30, 2022, cash used in investing activities was $2.1 million, which was related to purchases of property, plant and equipment, partially offset by sales of property and equipment.

During the nine months ended September 30, 2021, cash used in investing activities was $1.8 million, which was related to purchases of property, plant and equipment.

Financing Activities

During the nine months ended September 30, 2022, cash provided by financing activities was $35.4 million, consisting primarily of $19.1 million of proceeds from borrowings, net of debt discount and issuance costs, $16.3 million of proceeds from the issuance of common stock under the ATM Agreement, net of commissions and fees and proceeds from exercise of stock options of $0.4 million.

During the nine months ended September 30, 2021, cash provided by financing activities was $257.8 million, consisting primarily of $291.5 million of proceeds (net of $8.4 million of pre-Colonnade Merger costs relating to CLA) from the Colonnade Merger and PIPE Investment offset by offerings costs of $27.1 million, and proceeds from exercise of stock options of $0.5 million, partially offset by repayment of debt of $7.0 million. There were promissory notes to related parties of $5.0 million that were issued and repaid during the nine months ended September 30, 2021.

Critical Accounting Policies and Estimates

Our critical accounting policies and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2021. There have been no significant changes to our critical accounting policies since the filing of our Annual Report on Form 10-K for the year ended December 31, 2021 except for the addition of deferred debt financing costs as a significant accounting policy, which is described in Note 2 – Summary of Significant Accounting Policies to our unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.

The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions. Certain of these policies require the application of subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. These estimates and assumptions are based on historical experience, changes in the business environment and other factors that we believe to be reasonable under the circumstances. Different estimates that could have been applied in the current period or changes in the accounting estimates that are reasonably likely can result in a material impact on our financial condition and operating results in the current and future periods.

Goodwill Impairment. As of September 30, 2022, the Company with the assistance of third-party valuation specialist performed an impairment test of goodwill as a result of the decline in market conditions and updated outlook as a result of the impact of market uncertainties that prolonged the sales cycle. The Company’s goodwill valuation was determined based on a discounted future cash flow model (income approach). The Company determined that goodwill was not impaired as of September 30, 2022, however the fair value was not substantially in excess of its carrying value. The estimated fair value of the reporting unit exceeded its carrying value by approximately 4% as of September 30, 2022.

Given this level of fair value, in the event the financial performance of the Company does not meet expectations in the future or the Company experiences future prolonged market downturns or continued declines in our stock price, worsening trends from the COVID-19 pandemic, or there are other negative revisions to key assumptions, the Company may be required to perform additional impairment analyses and could be required to recognize a non-cash goodwill impairment charge. As of September 30, 2022, goodwill was $51.2 million.

Recent Accounting Pronouncements

Refer to Note 2 in our unaudited condensed consolidated financial statements contained elsewhere in this Quarterly Report on Form 10-Q for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted as of the date of this Quarterly Report on Form 10-Q.

Market risk

As filed, 4,608 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in interest rates and foreign currency exchange rates.

We do not believe that inflation has had a material effect on our business, results of operations or financial condition. Nonetheless, if our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs. Our inability or failure to do so could harm our business, results of operations or financial condition.

Inflation Risk

General inflation in the United States, Europe and other geographies has risen to levels not experienced in recent decades. General inflation, including rising prices for inputs and rising wages, as well as rising interest rates negatively impact our business by increasing our operating costs. General inflation also negatively impacts our business by decreasing the capital for our customers to deploy to purchase our products. Inflation may cause our customers to reduce or delay orders for our products thereby causing a decrease in sales. Increased instability relating to this higher inflation as well as rising interest rates may enhance volatility in currency exchange rates, limit our suppliers’ and customers’ access to credit and limit our ability to access debt and equity financing. These uncertainties may make it difficult for us and our suppliers and customers to accurately plan future business activities and materially adversely impact our operating results and financial condition. While we adjust our prices to try to offset rising operating costs, we may not be able to fully offset such higher costs or demand may decline. Our inability to offset costs or consequential decline in demand could harm our business, results of operations or financial condition.

Interest Rate Risk

As of September 30, 2022, we had cash and cash equivalents of approximately $133.2 million, out of which $129.9 million consisted of institutional money market funds, which carries a degree of interest rate risk. A hypothetical 10% change in interest rates would not have a material impact on our financial condition or results of operations due to the short-term nature of our investment portfolio.

In addition, our operating results are subject to risk from interest rate fluctuations on borrowings under our Loan Agreement, which carry variable interest rates. Interest rate risk is the exposure to loss resulting from changes in the level of interest rates and the spread between different interest rates. Because our borrowings under our Loan Agreement bear interest at variable rates, we are exposed to market risks relating to changes in interest rates. Interest rate risk is highly sensitive due to many factors, including U.S. monetary and tax policies, U.S. and international economic factors and other factors beyond our control. As of September 30, 2022, we had $19.2 million of variable rate debt outstanding under our Loan Agreement. Based upon a sensitivity analysis of our debt levels on September 30, 2022, an increase or decrease of 1% point in the effective interest rate would cause an increase or decrease in interest expense of approximately $0.2 million over the next 12 months. We do not use derivative financial instruments for speculative or trading purposes, but this does not preclude our adoption of specific hedging strategies in the future.

Foreign Currency Exchange Risk

Our results of operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates. Substantially all of our revenue is generated in U.S. dollars. Our expenses are generally denominated in the currencies of the jurisdictions in which we conduct our operations, which are primarily in the U.S. and to a lesser extent in Asia and Europe. Our results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates and may be adversely affected in the future due to changes in foreign exchange rates. The effect of a hypothetical 10% change in foreign currency exchange rates applicable to our business would not have a material impact on our historical consolidated financial statements. To date, we have not engaged in any hedging strategies. As our international operations grow, we will continue to reassess our approach to manage our risk relating to fluctuations in currency rates.

Controls and procedures

As filed, 6,951 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Limitations on Effectiveness of Controls and Procedures

We maintain disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well-designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of September 30, 2022 due to the material weaknesses in our internal control over financial reporting described below.

Material Weaknesses and Remediation Plan

We have identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

We did not design and maintain an effective control environment commensurate with our financial reporting requirements. Specifically, we did not maintain a sufficient complement of personnel with an appropriate degree of internal controls and accounting knowledge, experience, and training commensurate with our accounting and reporting requirements. This material weakness contributed to the following additional material weaknesses:

  • We did not design and maintain effective controls over the period-end financial reporting process to achieve complete, accurate and timely financial accounting, reporting and disclosures, including segregation of duties and adequate controls related to journal entries and certain other business processes, and verifying transactions are properly classified in the financial statements. This material weakness resulted in adjustments to several account balances and disclosures in the consolidated financial statements for the years ended December 31, 2019 and 2018, and adjustments to the equity and warrant liabilities accounts and related disclosures in the condensed consolidated financial statements for the three months ended March 31, 2021.
  • We did not design and maintain effective controls over certain information technology (“IT”) general controls for information systems that are relevant to the preparation of our consolidated financial statements. Specifically, we did not design and maintain (i) program change management controls to ensure that information technology program and data changes affecting financial IT applications and underlying accounting records are identified, tested, authorized and implemented appropriately and (ii) user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to our financial applications, programs and data to appropriate personnel. This material weakness did not result in a material misstatement to the consolidated financial statements, however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would not be prevented or detected.

Additionally, each of these material weaknesses could result in a misstatement of account balances or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.

We have taken several measures to remediate the foregoing material weaknesses. To date, our efforts have included the following:

  • Recruiting additional personnel with appropriate internal controls and accounting knowledge and experience commensurate with our accounting and reporting requirements, in addition to engaging and utilizing third party consultants and specialists.
  • Enhancing entity level controls (ELCs) including increasing Board and Audit Committee oversight, expanding senior management review of financial and business performance, creating an internal audit function and charter, and providing code of conduct trainings.
  • Strengthening IT governance and designing IT general controls including restricted user access to our internal systems for financial reporting, change management, program development and computer operations.
  • Designing additional controls for financial close and reporting including review of accounting policies, journal entry review controls, review of significant or non-routine transactions, period end close procedures, financial statement preparation, review, and reporting.

While these actions and planned actions are subject to ongoing management evaluation and will require validation and testing of the design and operating effectiveness of internal controls over a sustained period, we are committed to continuous improvement and will continue to diligently review our internal control over financial reporting.

Changes in Internal Control over Financial Reporting

Other than execution of the material weakness remediation plan activities described above, there has been no change in our internal control over financial reporting (as that term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended September 30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 7,796 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes from the risk factors disclosed in the Company’s Annual Report on Form 10-K filed with the SEC on February 28, 2022, as updated in the Company’s Quarterly Report on Form 10-Q filed with the SEC on August 5, 2022, other than the following:

We are subject to various risks related to the proposed merger with Velodyne.

We have entered into the Velodyne Merger Agreement pursuant to which we have agreed to merge with Velodyne (the “Velodyne Merger”). The risks, contingencies and other uncertainties that could result in the failure of the proposed merger to be completed or, if completed, that could have a material adverse effect on our business, financial condition or results of operations following the proposed transaction, and any anticipated benefits of the proposed merger, include:

  • the failure to obtain necessary stockholder approvals for the share issuance and the adoption of the Velodyne Merger Agreement;
  • the failure to satisfy required closing conditions, including regulatory approvals, or complete the proposed merger in a timely manner or at all;
  • the effect of the announcement of the proposed merger on each company’s ability to retain and hire key personnel, maintain business relationships, and on operating results and the businesses generally;
  • the diversion of our management’s attention from our core business as we work to take all steps necessary to close the transaction and realize expected synergies and cost-savings from a combined company;
  • any inability to achieve the anticipated synergies and our incurrence of significant transaction-related costs in connection with the proposed merger that are, and will be, incurred regardless of whether the proposed transaction is completed;
  • the potential loss of customers, distributors, suppliers, vendors, landlords and other business partners or the termination of existing contracts in response to the proposed transaction; and
  • the occurrence of any event giving rise to the right to terminate the Velodyne Merger Agreement.

Moreover, we have incurred and expect to incur a number of non-recurring costs associated with the proposed merger. These costs include financial advisory, legal, accounting, consulting and other advisory fees, severance/employee benefit-related costs, financing-related fees and costs, public company filing fees and other regulatory fees, printing costs and other related costs. Many of these costs are payable by us regardless of whether or not the proposed merger is completed.

Failure to complete the proposed merger may negatively impact our share price, the future business and our financial results.

If the proposed merger is not completed on a timely basis, our and Velodyne ongoing businesses may be adversely affected. If the proposed merger is not completed at all, we will be subject to a number of risks, including the following:

  • being required to pay costs and expenses relating to the merger, such as legal, accounting, financial advisory and printing fees; and
  • time and resources committed by our management to matters relating to the proposed merger could otherwise have been devoted to pursuing other beneficial opportunities.

If the proposed merger is not completed, the price of our common stock may decline to the extent that the current market price reflects a market assumption that the proposed merger will be completed and that the related benefits will be realized, or a market perception that the proposed merger was not completed due to an adverse change in our business.

We may be targets of securities class action and derivative lawsuits which could result in substantial costs and may delay or prevent the Velodyne Merger from being completed.

Securities class action lawsuits and derivative lawsuits are often brought against public companies that have entered into merger agreements. Even if the lawsuits are without merit, defending against these claims can result in substantial costs and divert management time and resources. An adverse judgment could result in monetary damages, which could have a negative impact on our liquidity and financial condition. Additionally, if a plaintiff is successful in obtaining an injunction prohibiting completion of the proposed merger, then that injunction may delay or prevent the proposed transaction from being completed, which may adversely affect our business, financial position and results of operation.

Adverse conditions in the industries we target or the global economy more generally could have adverse effects on our results of operations.

While we make our strategic planning decisions based on the assumption that the markets we are targeting will grow, our business is dependent, in large part on, and directly affected by, business cycles and other factors affecting the robotics, industrial automation, smart infrastructure, and transportation industries and global economy generally. Our target markets are highly cyclical and depend on general economic conditions and other factors, including consumer spending and preferences, changes in interest rates and credit availability, consumer confidence, inflation, environmental impact, governmental incentives and regulatory requirements, political volatility, labor relations issues, trade agreements and other factors.

For example, general inflation in the United States, Europe and other geographies has risen to levels not experienced in recent decades. General inflation, including rising prices for inputs and rising wages, as well as rising interest rates negatively impact our business by increasing our operating costs. General inflation also negatively impacts our business by decreasing the capital for our customers to deploy to purchase our products. Inflation may cause our customers to reduce or delay orders for our products thereby causing a decrease in sales. Increased instability relating to this higher inflation as well as rising interest rates may enhance volatility in currency exchange rates, limit our suppliers’ and customers’ access to credit and limit our ability to access debt and equity financing. These uncertainties may make it difficult for us and our suppliers and customers to accurately plan future business activities and materially adversely impact our operating results and financial condition.

There can be no assurance that we will be able to comply with the continued listing standards of the New York Stock Exchange (“NYSE”).

If we fail to satisfy the continued listing requirements of NYSE, such as the corporate governance requirements or the minimum share price requirement, NYSE may take steps to delist our securities. Such a delisting would likely have a negative effect on the price of the securities and would impair stockholders’ ability to sell or purchase the securities when they wish to do so. In the event of a delisting, we can provide no assurance that any action taken by us to restore compliance with listing requirements would allow our securities to become listed again, stabilize the market price or improve the liquidity of our securities, prevent our securities from dropping below the NYSE minimum share price requirement or prevent future non-compliance with NYSE’s listing requirements. Additionally, if our securities are not listed on, or become delisted from the NYSE, for any reason, and are quoted on the OTC Bulletin Board, an inter-dealer automated quotation system for equity securities that is not a national securities exchange, the liquidity and price of our securities may be more limited than if we were quoted or listed on the NYSE or another national securities exchange. Stockholders may be unable to sell their securities unless a market can be established or sustained.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-07-01 to 2022-09-30$11.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2022-01-01 to 2022-09-30$30.1mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-07-01 to 2022-09-30$7.5mus-gaap:CostOfRevenue
Cost of revenue9 months2022-01-01 to 2022-09-30$21.0mus-gaap:CostOfRevenue
Gross profit3 months2022-07-01 to 2022-09-30$3.7mus-gaap:GrossProfit
Gross profit9 months2022-01-01 to 2022-09-30$9.1mus-gaap:GrossProfit
Research and development3 months2022-07-01 to 2022-09-30$17.2mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2022-01-01 to 2022-09-30$49.0mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2022-07-01 to 2022-09-30−$36.0mus-gaap:OperatingIncomeLoss
Operating income9 months2022-01-01 to 2022-09-30−$103.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-07-01 to 2022-09-30$699.0kus-gaap:InterestExpense
Interest expense9 months2022-01-01 to 2022-09-30$1.1mus-gaap:InterestExpense
Income tax3 months2022-07-01 to 2022-09-30$37.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2022-01-01 to 2022-09-30$121.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-07-01 to 2022-09-30−$36.0mus-gaap:NetIncomeLoss
Net income9 months2022-01-01 to 2022-09-30−$96.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-07-01 to 2022-09-30−$0.20us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2022-01-01 to 2022-09-30−$0.55us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-07-01 to 2022-09-30−$0.20us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-01-01 to 2022-09-30−$0.55us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-07-01 to 2022-09-30181,361,354 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2022-01-01 to 2022-09-30175,795,093 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2022-01-01 to 2022-09-30−$83.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2022-01-01 to 2022-09-30$2.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2022-01-01 to 2022-09-30$46.0kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-09-30$133.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-09-30$171.9mus-gaap:AssetsCurrent
Total assetsAt period end2022-09-30$266.3mus-gaap:Assets
Current liabilitiesAt period end2022-09-30$25.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-09-30$61.0mus-gaap:Liabilities
Long-term debtAt period end2022-09-30$19.2mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2022-09-30$205.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-22-028989. Last ingested by Listed: Nov 13, 2026, 15:37 ET. Listed shows no prices and gives no investment advice.